Genotyping and transmission analysis of Mycobacterium tuberculosis in a pediatric population in Czech Republic and Slovakia.

Publication date: Jul 03, 2025

Tuberculosis remains a global health concern, with rising pediatric and adolescent cases. The advancement of diagnostic strategies is crucial for effective control, with whole-genome sequencing emerging as a promising tool. This study explores using whole-genome sequencing in pediatric Tuberculosis. Mycobacterium tuberculosis isolates from pediatric patients and their contacts were collected between January 2023 and June 2024 in Slovakia and the Czech Republic. The isolates were subjected to WGS to characterize the resistance patterns and transmission. The study included 37 patients in total-30 pediatric cases and 7 adult index cases-with a single M. tuberculosis isolate collected per patient. The phylogenetic analysis results revealed that 32 out of 37 (86. 5%) isolates belonged to the Euro-American lineage. Five isolates (13. 5%) belonged to the East-Asian lineage. Genotypic resistance to at least one drug was confirmed in 6 patients (16%). 24 patients were divided into 9 clusters (65%), leaving 13 unclustered (35%). Moreover, the concordance between the identification of source case by WGS and epidemiological anamnesis was confirmed in 60% of patients. Epidemiological data may not always provide accurate insights into the transmission of TB. Consequently, integrating molecular methods, such as WGS, is essential to enhance the reliability and precision of epidemiological analyses.

Open Access PDF

Concepts Keywords
Czech Adolescent
Genotyping Adult
January Child
June Child, Preschool
Tuberculosis Czech Republic
Drug resistance
Female
Genotype
Humans
Infant
Male
Mycobacterium tuberculosis
Pediatric patients, tuberculosis
Phylogeny
Slovakia
Transmission chains
Tuberculosis
Whole Genome Sequencing
Whole-genome sequencing

Semantics

Type Source Name
disease MESH Tuberculosis
pathway KEGG Tuberculosis
pathway REACTOME Reproduction
disease MESH Infectious Diseases
drug DRUGBANK Ilex paraguariensis leaf
disease IDO contact tracing
disease IDO country
disease MESH infection
drug DRUGBANK Trestolone
disease IDO drug susceptibility
disease MESH relapse
drug DRUGBANK Rifampicin
drug DRUGBANK Nitazoxanide
drug DRUGBANK Ethambutol
drug DRUGBANK Pyrazinamide
disease IDO susceptibility
drug DRUGBANK Streptomycin
drug DRUGBANK Kanamycin
drug DRUGBANK Ethionamide
drug DRUGBANK Serine
drug DRUGBANK Moxifloxacin
disease IDO assay
disease IDO reagent
drug DRUGBANK Ademetionine
disease IDO history
disease IDO facility
drug DRUGBANK Isoniazid
disease MESH abscess
drug DRUGBANK Coenzyme M
drug DRUGBANK Amikacin
drug DRUGBANK Capreomycin
drug DRUGBANK L-Phenylalanine
disease IDO primary infection
disease MESH privacy
disease MESH Respiratory Diseases
disease MESH Lung Diseases
disease MESH Pneumonia
disease IDO intervention
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH latent tuberculosis infection
disease MESH malnutrition
disease MESH extrapulmonary tuberculosis
disease MESH pulmonary tuberculosis
disease IDO host

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *